Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”),
Texas and Oklahoma — which joined the conference on July 1 — and slight increases in the amounts provided to the 14 incumbent ...
1don MSN
Sony shares popped after it raised its 2024 outlook for annual operating profit to 1.34 trillion yen ($8.76 billion), a 2% ...
today reported certain preliminary unaudited financial results for the full year ended December 31, 2024, including cash, cash equivalents, and revenues, and also provided a business update.
IWATA, Japan-- ( BUSINESS WIRE )--Yamaha Motor Co., Ltd. (Tokyo: 7272) announces its consolidated business results for the ...
Mississippi State athletics operated at a deficit for the 2024 fiscal year, according to documents obtained by the Clarion ...
Read about Iridium's fourth-quarter and full-year 2024 financial results, including the revenue performance of its U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback